294 related articles for article (PubMed ID: 25782683)
1. Understanding drug resistance in human intestinal protozoa.
El-Taweel HA
Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
[TBL] [Abstract][Full Text] [Related]
2. Therapy of intestinal protozoa.
Petri WA
Trends Parasitol; 2003 Nov; 19(11):523-6. PubMed ID: 14580964
[No Abstract] [Full Text] [Related]
3. [New drugs for the treatment of human parasitic protozoa].
Dupouy-Camet J
Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
[TBL] [Abstract][Full Text] [Related]
4. Treatment of parasitic diarrhea in HIV-infected patients.
Derouin F; Lagrange-Xelot M
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):337-49. PubMed ID: 18588498
[TBL] [Abstract][Full Text] [Related]
5. New mechanisms of drug resistance in parasitic protozoa.
Borst P; Ouellette M
Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
Harder A; Greif G; Haberkorn A
Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
[TBL] [Abstract][Full Text] [Related]
7. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
8. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerases as targets for antiprotozoal therapy.
Bakshi RP; Shapiro TA
Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
[TBL] [Abstract][Full Text] [Related]
10. [Drugs for protozoan diseases].
Ohta N
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():380-3. PubMed ID: 17455649
[No Abstract] [Full Text] [Related]
11. Traveler's diarrhea due to intestinal protozoa.
Okhuysen PC
Clin Infect Dis; 2001 Jul; 33(1):110-4. PubMed ID: 11389503
[TBL] [Abstract][Full Text] [Related]
12. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for the eradication of intestinal protozoa.
Farthing MJ
Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):436-45. PubMed ID: 16883348
[TBL] [Abstract][Full Text] [Related]
14. [Intestinal protozoa infections].
Weinke T; Liebold I
Dtsch Med Wochenschr; 2013 Apr; 138(14):709-11. PubMed ID: 23533035
[No Abstract] [Full Text] [Related]
15. Reporter genes facilitating discovery of drugs targeting protozoan parasites.
Dube A; Gupta R; Singh N
Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564
[TBL] [Abstract][Full Text] [Related]
16. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
Rodrigues JC; de Souza W
Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
[TBL] [Abstract][Full Text] [Related]
19. Targeting the cell cycle in the pursuit of novel chemotherapies against parasitic protozoa.
Grant KM
Curr Pharm Des; 2008; 14(9):917-24. PubMed ID: 18473840
[TBL] [Abstract][Full Text] [Related]
20. The essential features of microorganisms and the rationale for antimicrobial therapy.
Douglas CW
Br Dent J; 1992 May; 172(9):339-43. PubMed ID: 1389584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
